Vorolanib相关论文
Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advance
Objective: This study evaluated the safety and preliminary efficacy of vorolanib,a novel tyrosine kinase inhibitor,for t......